The SPINK Protein Family in Cancer: Emerging Roles in Tumor Progression, Therapeutic Resistance, and Precision Oncology
Open Access
- 13 August 2025
- journal article
- review article
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (8) , 1194
Abstract
The serine protease kazal-type inhibitor (SPINK) family is central to the regulation of proteolytic function, the establishment of physiological homeostasis, and the development of many disease states, including cancer. Emerging research has identified that members of the SPINK family are commonly overexpressed in most malignancies and are deeply implicated in pivotal oncogenic pathways like cell growth, epithelial-to-mesenchymal transition (EMT), metastasis, and drug resistance. This review provides an in-depth examination of structural and functional characteristics of SPINK proteins and their involvement in the onset and development of multiple cancers, which include prostrate, pancreatic, and colorectal carcinomas. Significantly, SPINK proteins regulate major signalling pathways, including EGFR, NF-κB, and MAPK, highlighting their role as prognostic biomarkers and therapeutic targets. The review underscores the most recent advancements in therapeutic strategies for SPINK-related pathways and outlines the bottlenecks that have restricted their use in the clinic. By integrating current evidence, this work signals the potential of SPINK proteins as good precision oncology candidates with novel options for cancer prognosis, treatment, and management.Keywords
Funding Information
- King Khalid University (RGP2/179/46)
- Ajman University (RGP2/179/46)
This publication has 242 references indexed in Scilit:
- The antiprotease Spink7 promotes inflammation resolution by modulating multiple proteases activities during wound healingClinical and Translational Medicine, 2025
- SPINK5 inhibits esophageal squamous cell carcinoma metastasis via immune activityThe Journal of Gene Medicine, 2024
- Reconstructing the epidermal proteolytic cascades in health and diseaseThe Journal of Pathology, 2022
- Mitochondrial protein import dysfunction: mitochondrial disease, neurodegenerative disease and cancerFEBS Letters, 2020
- Mitochondrial DNA copy number in human disease: the more the better?FEBS Letters, 2020
- Comprehensive bioinformatics analysis identifies lncRNA HCG22 as a migration inhibitor in esophageal squamous cell carcinomaJournal of Cellular Biochemistry, 2019
- A novel tumor suppressor SPINK5 targets Wnt/β‐catenin signaling pathway in esophageal cancerCancer Medicine, 2019
- Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behavior of bladder cancerInternational Journal of Cancer, 2018
- Intrafamily and Interfamilial Phenotype Variation and Immature Immunity in Patients With Netherton Syndrome and FinnishSPINK5Founder MutationJAMA Dermatology, 2016
- Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancerEMBO Molecular Medicine, 2011